Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$17.3 million.

  • Gossamer Bio's Net Cash Flow rose 7046.29% to -$17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year increase of 6404.59%. This contributed to the annual value of $14.1 million for FY2024, which is 11758.95% up from last year.
  • Latest data reveals that Gossamer Bio reported Net Cash Flow of -$17.3 million as of Q3 2025, which was up 7046.29% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Net Cash Flow ranged from a high of $59.6 million in Q3 2022 and a low of -$58.5 million during Q3 2024
  • For the 4-year period, Gossamer Bio's Net Cash Flow averaged around -$11.6 million, with its median value being -$17.3 million (2025).
  • As far as peak fluctuations go, Gossamer Bio's Net Cash Flow skyrocketed by 27017.61% in 2024, and later tumbled by 35173.12% in 2025.
  • Over the past 4 years, Gossamer Bio's Net Cash Flow (Quarter) stood at -$42.1 million in 2022, then dropped by 20.3% to -$50.7 million in 2023, then skyrocketed by 134.99% to $17.7 million in 2024, then tumbled by 197.44% to -$17.3 million in 2025.
  • Its last three reported values are -$17.3 million in Q3 2025, -$2.8 million for Q2 2025, and -$17.2 million during Q1 2025.